Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ITH Immune Therapy Holdings AB
AB
Active
Org 5566814371
Sollentuna
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2005
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ITH Immune Therapy Holdings AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SJ
Stig Jonas Winqvist
Chief Executive Officer
Chief Executive Officer
2022
Former (2)
AA
Ahsan Amjad
Chief Executive Officer
Chief Executive Officer
2020 – 2022
JH
Johan Henrik Magnusson Luther
Chief Auditor
Chief Auditor
2020 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
ÅS
Åke Stefan Warin
Board of Directors
2020
SO
Stig Ola Winqvist
Chairman
2022
Former (1)
HO
Hans Olof Glise
Chairman
2020 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on ITH Immune Therapy Holdings AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
